Stay updated on IDH-Targeted vs Non-Targeted Therapies in Newly Diagnosed AML Clinical Trial
Sign up to get notified when there's something new on the IDH-Targeted vs Non-Targeted Therapies in Newly Diagnosed AML Clinical Trial page.

Latest updates to the IDH-Targeted vs Non-Targeted Therapies in Newly Diagnosed AML Clinical Trial page
- Check3 days agoNo Change Detected
- Check10 days agoChange DetectedThe record history shows a capitalization tweak of the contact information label and a new revision tag (v3.7.0) replacing the previous v3.6.6, reflecting a small metadata/UI update rather than substantive content changes.SummaryDifference0.2%

- Check17 days agoNo Change Detected
- Check31 days agoChange DetectedNew revision v3.6.6 appears in the Study Record History, replacing the prior v3.6.5. This update reflects an internal metadata change to the record rather than a modification of core study content.SummaryDifference0.1%

- Check52 days agoChange DetectedA new site release entry Revision: v3.6.5 was added to the record history, replacing the previous Revision: v3.6.4.SummaryDifference0.1%

- Check67 days agoChange DetectedThe record history adds a new release entry, Revision: v3.6.4, and removes the previous entry, Revision: v3.6.3, reflecting an update to the site's release notes in the study record history.SummaryDifference0.1%

- Check88 days agoChange DetectedA newer revision tag (v3.6.3) was added to the study record history, indicating a minor update to the page; the previous revision (v3.6.2) was superseded in the log.SummaryDifference0.1%

- Check95 days agoChange DetectedThe record history gained new entries noting updates to Contacts/Locations and Study Status (version 11, Revision: v3.6.2) on 2026-06-23, while an earlier revision entry (Revision: v3.6.0 dated 2026-06-08) was removed.SummaryDifference0.6%

Stay in the know with updates to IDH-Targeted vs Non-Targeted Therapies in Newly Diagnosed AML Clinical Trial
Enter your email address, and we'll notify you when there's something new on the IDH-Targeted vs Non-Targeted Therapies in Newly Diagnosed AML Clinical Trial page.